Did Bharat Biotech Follow Covaxin Clinical Protocols in Bhopal?

<div>On 3 January 2021, Covaxin became India's first indigenously produced vaccine against the novel coronavirus to get 'emergency approval in public health interest in clinical trial mode.’ </div> <div><br> </div> <div>The vaccine is jointly made by Bharat Biotech, Indian Council of Medical Research and National Institute of Virology. </div> <div><br> </div> <div>However, its approval raised many questions, especially since phase 3 clinical trials were still ongoing and no efficacy data had been published.</div> <div><br> </div> <div>Several media outlets in January 2021 reported on the vaccine’s clinical trial at People’s Hospital Bhopal, one of the several sites where phase 3 trials are taking place. The reports pointed to how poor people were lured without any understanding that they were taking part in a vaccine trail and not a vaccination drive. </div> <div><br> </div> <div>There has been one death and several participants have reported illnesses at this site. </div> <div><br> </div> <div>Why are there fears of ethical breaches in the clinical trail and what does it mean for Covaxin?</div> <div> <br> <strong>Producer and Host: </strong>Himmat Shaligram<br> <strong>Guest:<br> </strong>Priyanka Pulla, freelance science journalist</div> <div> <strong>Editor:</strong> Shelly Walia<br> <br> </div> <div> <strong>Music:</strong> Big Bang Fuzz<br> <br> <strong>Listen to The Big Story podcast on:</strong> </div> <div><br> </div> <div>Apple: <a href="https://www.youtube.com/redirect?q=https%3A%2F%2Fapple.co%2F2AYdLIl&amp;redir_token=G9sQMbbppKv-LEFD29gDyTmPMzt8MTU3MTM4MDU5NkAxNTcxMjk0MTk2&amp;v=xkpX1V6aUFo&amp;event=video_description">https://apple.co/2AYdLIl</a> </div> <div>Saavn: <a href="https://www.youtube.com/redirect?q=http%3A%2F%2Fbit.ly%2F2oix78C&amp;redir_token=G9sQMbbppKv-LEFD29gDyTmPMzt8MTU3MTM4MDU5NkAxNTcxMjk0MTk2&amp;v=xkpX1V6aUFo&amp;event=video_description">http://bit.ly/2oix78C</a> </div> <div>Google Podcasts: <a href="https://www.youtube.com/redirect?q=http%3A%2F